Lista de obras - Chad Bousman - Dominio Público Uruguay

"Black box" pharmacogenetic decision-support tools in psychiatry

scientific article published on 24 January 2020

ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression

artículo científico publicado en 2012

Alpha-5 and -3 nicotinic receptor gene variants predict nicotine dependence but not cessation: findings from the COMMIT cohort

artículo científico publicado en 2012

Antidepressant pharmacogenetics

artículo científico

Assessing neuropsychological performance in a migrant farm working Colonia in Baja California, Mexico: a feasibility study.

artículo científico publicado en 2011

Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis.

artículo científico publicado en 2013

Chronic illness histories of adults entering treatment for co-occurring substance abuse and other mental health disorders

artículo científico publicado en 2011

Correlation of major depressive disorder symptoms with FKBP5 but not FKBP4 expression in human immunodeficiency virus-infected individuals

artículo científico publicado en 2010

Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: preliminary findings

artículo científico publicado en 2010

Dopamine receptor D3 genetic polymorphism (rs6280TC) is associated with rates of cognitive impairment in methamphetamine-dependent men with HIV: preliminary findings

artículo científico publicado en 2011

Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosis. ⬇️

artículo científico publicado en 2013

Effects of neuregulin-1 genetic variation and depression symptom severity on longitudinal patterns of psychotic symptoms in primary care attendees

artículo científico publicado en 2013

Erythrocyte polyunsaturated fatty acid composition is associated with depression and FADS genotype in Caucasians.

artículo científico publicado en 2017

Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis

artículo científico publicado en 2007

Formative Assessment of ARM-U: A Modular Intervention for Decreasing Risk Behaviors Among HIV-Positive and HIV-Negative Methamphetamine-Using MSM

artículo científico publicado en 2010

Functional brain networks in treatment-resistant schizophrenia.

artículo científico publicado en 2016

G-protein β3 subunit genetic variation moderates five-year depressive symptom trajectories of primary care attendees

artículo científico publicado en 2014

Genetic association studies of methamphetamine use disorders: A systematic review and synthesis

artículo científico publicado en 2009

High impact child abuse may predict risk of elevated suicidality during antidepressant initiation

artículo científico

Homelessness and neuropsychological impairment: preliminary analysis of adults entering outpatient psychiatric treatment

artículo científico publicado en 2010

Impact of COMT Val158Met on executive functioning in the context of HIV and methamphetamine

scientific article published on January 2010

Investigation of peripheral complement factors across stages of psychosis

artículo científico publicado en 2018

Kava for the treatment of generalized anxiety disorder RCT: analysis of adverse reactions, liver function, addiction, and sexual effects.

artículo científico publicado en 2013

Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study.

artículo científico publicado en 2013

Methylenetetrahydrofolate reductase (MTHFR) genetic variation and major depressive disorder prognosis: A five-year prospective cohort study of primary care attendees

artículo científico publicado en 2013

Negative Symptoms of Psychosis Correlate with Gene Expression of the Wnt/β-Catenin Signaling Pathway in Peripheral Blood

artículo científico publicado en 2013

Negative mood and sexual behavior among non-monogamous men who have sex with men in the context of methamphetamine and HIV

artículo científico publicado en 2009

O1.6. INCREASED COMPLEMENT FACTORS C3 AND C4 IN SCHIZOPHRENIA AND THE EARLY STAGES OF PSYCHOSIS: IMPLICATIONS FOR CLINICAL SYMPTOMATOLOGY AND CORTICAL THICKNESS.

artículo científico publicado en 2018

Oestrogen alpha-receptor variant and two-year memory decline in midlife Australian women

artículo científico publicado en 2012

Parenting × Brain Development interactions as predictors of adolescent depressive symptoms and well-being: Differential susceptibility or diathesis-stress?

scientific article published on 01 February 2020

Pharmacogenetic Testing Options Relevant to Psychiatry in Canada

artículo científico publicado en 2020

Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depression

artículo científico publicado en 2013

Positive symptoms of psychosis correlate with expression of ubiquitin proteasome genes in peripheral blood

artículo científico publicado en 2010

Preliminary evidence of ethnic divergence in associations of putative genetic variants for methamphetamine dependence

artículo científico publicado en 2010

Preliminary evidence of motor impairment among polysubstance 3,4-methylenedioxymethamphetamine users with intact neuropsychological functioning

artículo científico publicado en 2010

Preliminary evidence of ubiquitin proteasome system dysregulation in schizophrenia and bipolar disorder: convergent pathway analysis findings from two independent samples

artículo científico publicado en 2010

Psychomotor depressive symptoms may differentially respond to venlafaxine

artículo científico publicado en 2013

Reply to Dawes et al

scientific article published on 19 May 2020

Risk and resilience brain networks in treatment-resistant schizophrenia.

artículo científico publicado en 2017

The acute effects of kava and oxazepam on anxiety, mood, neurocognition; and genetic correlates: a randomized, placebo-controlled, double-blind study

artículo científico publicado en 2012

Thoughtful Clinical Use of Pharmacogenetics in Child and Adolescent Psychopharmacology

artículo científico publicado en 2020

Lista de obras de Chad Bousman

"Black box" pharmacogenetic decision-support tools in psychiatry

ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression

Alpha-5 and -3 nicotinic receptor gene variants predict nicotine dependence but not cessation: findings from the COMMIT cohort

Antidepressant pharmacogenetics

Assessing neuropsychological performance in a migrant farm working Colonia in Baja California, Mexico: a feasibility study.

Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis.

Chronic illness histories of adults entering treatment for co-occurring substance abuse and other mental health disorders

Correlation of major depressive disorder symptoms with FKBP5 but not FKBP4 expression in human immunodeficiency virus-infected individuals

Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: preliminary findings

Dopamine receptor D3 genetic polymorphism (rs6280TC) is associated with rates of cognitive impairment in methamphetamine-dependent men with HIV: preliminary findings

Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosis. ⬇️

Effects of neuregulin-1 genetic variation and depression symptom severity on longitudinal patterns of psychotic symptoms in primary care attendees

Erythrocyte polyunsaturated fatty acid composition is associated with depression and FADS genotype in Caucasians.

Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis

Formative Assessment of ARM-U: A Modular Intervention for Decreasing Risk Behaviors Among HIV-Positive and HIV-Negative Methamphetamine-Using MSM

Functional brain networks in treatment-resistant schizophrenia.

G-protein β3 subunit genetic variation moderates five-year depressive symptom trajectories of primary care attendees

Genetic association studies of methamphetamine use disorders: A systematic review and synthesis

High impact child abuse may predict risk of elevated suicidality during antidepressant initiation

Homelessness and neuropsychological impairment: preliminary analysis of adults entering outpatient psychiatric treatment

Impact of COMT Val158Met on executive functioning in the context of HIV and methamphetamine

Investigation of peripheral complement factors across stages of psychosis

Kava for the treatment of generalized anxiety disorder RCT: analysis of adverse reactions, liver function, addiction, and sexual effects.

Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study.

Methylenetetrahydrofolate reductase (MTHFR) genetic variation and major depressive disorder prognosis: A five-year prospective cohort study of primary care attendees

Negative Symptoms of Psychosis Correlate with Gene Expression of the Wnt/β-Catenin Signaling Pathway in Peripheral Blood

Negative mood and sexual behavior among non-monogamous men who have sex with men in the context of methamphetamine and HIV

O1.6. INCREASED COMPLEMENT FACTORS C3 AND C4 IN SCHIZOPHRENIA AND THE EARLY STAGES OF PSYCHOSIS: IMPLICATIONS FOR CLINICAL SYMPTOMATOLOGY AND CORTICAL THICKNESS.

Oestrogen alpha-receptor variant and two-year memory decline in midlife Australian women

Parenting × Brain Development interactions as predictors of adolescent depressive symptoms and well-being: Differential susceptibility or diathesis-stress?

Pharmacogenetic Testing Options Relevant to Psychiatry in Canada

Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depression

Positive symptoms of psychosis correlate with expression of ubiquitin proteasome genes in peripheral blood

Preliminary evidence of ethnic divergence in associations of putative genetic variants for methamphetamine dependence

Preliminary evidence of motor impairment among polysubstance 3,4-methylenedioxymethamphetamine users with intact neuropsychological functioning

Preliminary evidence of ubiquitin proteasome system dysregulation in schizophrenia and bipolar disorder: convergent pathway analysis findings from two independent samples

Psychomotor depressive symptoms may differentially respond to venlafaxine

Reply to Dawes et al

Risk and resilience brain networks in treatment-resistant schizophrenia.

The acute effects of kava and oxazepam on anxiety, mood, neurocognition; and genetic correlates: a randomized, placebo-controlled, double-blind study

Thoughtful Clinical Use of Pharmacogenetics in Child and Adolescent Psychopharmacology